drugset / Trial / NCT00084409
Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
Phase 2
Completed
152 enrolled
University of Colorado, Denver
National Cancer Institute (NCI) · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. Iloprost may be effective in preventing lung cancer. PURPOSE: This randomized phase II trial is studying how well iloprost works in preventing lung cancer in patients who are at high risk for this disease.
Timeline
- Start
- 2001-11
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iloprost | Other / unclassified | — | Oral |